A continuous-flow left ventricular assist device (LVAD) improved survival free from disabling stroke compared with a pulsatile LVAD, when used as destination therapy over a 2-year period in ...

The HeartMate II is currently the only continuous-flow left-ventricular assist device (LVAD) approved by the FDA for both bridge-to-transplantation and destination therapy. Because of its ...

The use of mechanical support of the circulation with ventricular assist devices for refractory heart failure is increasing. This is due to expanding indications, including for acute heart failure ...

LVAD patients do not have a pulse or measurable blood pressure, as they have continuous blood flow created by a rotating impeller within the pump. A permanent LVAD is currently being used in some ...

A former college track athlete and mother of five hopes her story might save lives and inspire others to listen to their ...